Biotech Investors & VC Firms in Boston
73 firms in this list, with a median first check of $1M. 19 of them lead rounds. Generated from verified public data and updated continuously.
3CC | Third Culture Capital
BostonPre-Seed–Series A$250K – $1M
6 people
6 Dimensions Capital
Grand CaymanSeed–Late Stage
19 people
Luma Group
BostonSeed–Late Stage
13 people
BOLD Longevity
BostonGrowth–Late Stage
9 people
PureTech Health
Boston
11 people
NYBC Ventures
New YorkSeed–Series B
8 people
Newpath Partners
BostonSeed–Series A$50K – $10M
3 people
Kendall Capital Partners
BostonSeed–Growth
6 people
Fletcher Spaght, Inc.
BostonLate Stage
9 people
Golden Eagle
Boston
7 people
Taihill Venture
CambridgePre-Seed–Series A
7 people
Accelr8
BostonPre-Seed–Seed
1 person
Chiesi Ventures
BostonSeed–Series A$5M
2 people
Boston Millennia Partners
BostonSeed–Late Stage$3M – $5M
7 people
Grantham Foundation
BostonPre-Seed–Series A
2 people
quadraScope Venture Fund
Boston
2 people
Dewpoint Therapeutics
Cambridge
1 person
Ginkgo Bioworks
Boston
1 person
Unveil Pharma
BostonPre-Seed–Series A
1 person
Curie.Bio
CambridgeSeed–Series A$7M
7 people
EQx Fund
BostonPre-Seed–Late Stage
Mass General Brigham Ventures
BostonSeed–Series A
HighVista
BostonSeed–Series A
Polaris Partners
BostonSeed–Growth
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.





































